Yeah Gilles, and the Novartis team were fantastic collaboration partners. They performed the transporter assays for SLC39A8/ ZIP8 (Figure 6E). Showing that the identified interaction partners after knock-down directly affect transport activity of SLC39A8.

I've noticed this as well, though only on Massive, not in PRIDE. It doesn't make sense to me. I reject it during revisions and say that I can't evaluate the deposited data.